Protective role of liposome incorporated lipopolysaccharide antigen of Klebsiella pneumoniae in a rat model of lobar pneumonia

Japanese Journal of Infectious Diseases

Volumn 57, Issue 4, 2004, Pages 150-155

  Chhibber, Sanjay ^a   Wadhwa, Sunita ^a   Yadav, Vanashree ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; LIPOSOME; PYROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; KLEBSIELLA PNEUMONIAE; LETHALITY; LOBAR PNEUMONIA; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; RAT;

ANIMALS; ANTIGENS, BACTERIAL; DISEASE MODELS, ANIMAL; FEMALE; IMMUNIZATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; LIPOSOMES; MACROPHAGES, ALVEOLAR; PHAGOCYTOSIS; PNEUMONIA, PNEUMOCOCCAL; RABBITS; RATS; RATS, WISTAR;

EID: 4644335447     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Campbell, G. D. (1994): Overview of community acquired pneumonia: prognosis and clinical feature. Med. Clin. North. Am., 78, 1035-1048.
2. Podschun, R. and Ullmann, U. (1998): Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Clin. Microbiol. Rev., 11, 589-603.
3. Jay, S. J. (1983): Nosocomial pneumonia. Nosocomial Infect., 74, 221-224.
4. Mackenzie, F. M., Forbes, K. J., Dorai, J. T., Amyes, S. G. B. and Gould, I. M. (1997): Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet, 350-783.
5. Cryz, S. J. Jr., Mortimer, P. M., Manifield, V. and Germanier, R. (1986): Seroepidemiology of Klebsiella pneumoniae isolates and implications for vaccine development. J. Clin. Microbiol., 23, 689-690.
6. Cryz, S. J. Jr., Mortimer, P. M., Cross, A. S., Fuerer, E. and Germanier, R. (1986b): Safety and immunogenicity of a polyvalent Klebsiella capsular polysacchride vaccine in humans. Vaccine, 4, 15-20.
7. Cryz, S. J. Jr., (1983): Progress in immunization against Klebsiella pneumoniae infections. Eur. J. Clin. Microbiol, 2, 523-528.
8. Memo, Y. and Ameko, K. (1990): Morphological evidence for penetration of anti-O-antibody through the capsule of Klebsiella pneumoniae. Infect. Immun., 58, 421-428.
9. Westphal, O. and Jann, K. (1965): Bacterial lipopolysaccharide extraction with phenol-water and further application of the procedure. p. 83-910. In Wistler R.L. (ed.), Methods in Carbohydrate Chemistry. Academic Press, Inc., New York.
10. Morrison, D. C. and Leive, L. ( 1975): Fractions of lipopolysaccharides from E. coli 0111: B4 prepared by two extraction procedures. J. Biol. Chem., 250, 2911-2919.
11. Johnson, K. G. and Perry, M. B. (1976): Improved techniques for the preparation of bacterial lipopolysaccharides. Can. J. Microbiol., 22, 29-34.
12. Burton, K. (2000): Diphenylamine method for DNA estimation. Biochem. J., 62, 315-322.
13. Lowry, O. H., Rosenbrough, N. J., Farr, A. L. and Randall, A. J. (1951): Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-274.
14. Munro, H. N. and Fleck, A. (1966): The determination of nucleic acids. Methods Biochem. Anal., 14, 113-176.
15. Dijkstra, J., Ryan, J. L. and Szoka, F. C. (1988): A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies. J. Immunol. Methods, 114, 197-205.
16. Rani, M., Gupta, R. K. and Chhibber, S. (1990): Protection against Klebsiella pneumoniae induced lobar pneumonia in rats with lipopolysaccharide and its related antigens. Can. J. Microbiol., 36, 885-890.
17. Allen, P. M., Fisher, D., Saundere, J. R. and Hart, C. A. (1987): The role of capsular polysaccharide k21b of Klebsiella and of the structurally related colanic-acid polysaccharide of E. coli in resistance to phagocytosis and serum killing. J. Med. Microbiol., 24, 363-370.
18. Sugar, A. M., Brummer, E. and Stevens, D. A. (1983): Murine pulmonary macrophages: Evaluation of lung lavage fluids miniaturized monolayers and candidacidal activity. Am. Rev. Respir. Dis., 27, 110-112.
19. Hiernaux, J. R., Baker, R. J., Delisi, C. and Rudhach, J. A. (1982): Modulation of the immune response to lipopolysaccharide. J. Immunol., 128, 1054-1058.
20. Desiderio, J. V. and Campbell, S. G. (1985): Immunization against experimental murine salmonellosis with liposome associated O-antigen. Infect. Immun., 48, 658-663.
21. Chhibber, S. and Bajaj, J. (1995): Polysaccharide-iron regulated cell surface protein conjugate vaccine; Its role in protection against Klebsiella pneumoniae induced lobar pneumonia. Vaccine, 13, 34-36.
22. Dijkstra, J., Mellors, J. W., Ryan, J. L. and Szoka, F. C. (1987): Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J. Immunol., 138, 2663-2670.
23. Bennett-Guerrero, E., McIntosh, T. J., Barclay, G. R., Snyder, D. S., Gibbs, R. J., Mythen, M. G. and Poxton, I. R. (2000): Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine. Infect. Immun., 68, 6202-6208.
24. Gregoridadis, G. (1990): Immunological adjuvants: role for liposomes. Immunol. Today, 11, 89-97.
25. Fortin, A. and Therien, H. M. (1993): Mechanism of liposome adjuvanticity: an in vivo approach. Immunobiology, 188, 316-322.
26. Cluff, C. W. and Ziegler, K. K. (1987): An early response to lipopolysaccharide in the elicitation of macrophages specialized for antigen degradation with negative regulatory effects on the induction of specific immune response. Infect. Immun., 55, 1346-1354.
27. Farr, A. G., Wcjter, W. J., Kiehy, J. M. and Unanue, E. R. (1979): Induction of cytocidal macrophages following interaction between listeria, immune T-cells and macrophages. A role of H.2. J. Immunol., 122, 2405-2412.
28. Ziegler, H. K. and Unanue, E. R. (1981): Identification of a macrophage antigen processing event required for I region restricted antigen presentation for T-lymphocytes. J. Immunol., 127, 1869-1875.
29. Garcon, N. and Six, H. R. (1991): Universal vaccine carrier liposomes that provide T dependent help to weak antigens. J. Immunol., 146, 3697-3701.